Sign in

CIK 0001534969

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SERA PROGNOSTICS, INC.

Sign in to watch
Ticker
SERA
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261911522
Phone
+1 801-990-0520
Business address
2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
Former names
SERA PROGNOSTICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,563
in 6 filings

Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-07-27 Boniface John J. Chief Scientific Officer Sale −1,000 $2.22 $2K 46,510
2022-07-27 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,000 844
2022-07-26 Boniface John J. Chief Scientific Officer Sale −2,725 $2.15 $6K 46,510
2022-07-19 Boniface John J. Chief Scientific Officer Sale −2,725 $1.86 $5K 49,235
2022-07-18 Blue Ox Healthcare Partners, LLC 10% owner Other disposition −1,383,094 132,501
2022-07-18 Blue Ox Healthcare Partners, LLC 10% owner Other disposition −997,627 77,420
2022-07-18 Blue Ox Healthcare Partners, LLC 10% owner Other disposition −1,157,764 46,744
2022-07-12 Boniface John J. Chief Scientific Officer Sale −2,725 $1.84 $5K 51,960
2022-07-05 Boniface John J. Chief Scientific Officer Sale −2,725 $1.63 $4K 54,685
2022-06-29 Boniface John J. Chief Scientific Officer Exercise or conversion +1,000 $0.73 $730 58,410
2022-06-29 Boniface John J. Chief Scientific Officer Sale −1,000 $1.72 $2K 57,410
2022-06-29 Boniface John J. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −1,000 1,844
2022-06-28 Boniface John J. Chief Scientific Officer Sale −2,725 $1.89 $5K 57,410
2022-06-21 Boniface John J. Chief Scientific Officer Sale −2,725 $1.31 $4K 60,135
2022-06-14 Jackson Benjamin General Counsel Purchase +8,000 $1.20 $10K 8,000
2022-06-14 Boniface John J. Chief Scientific Officer Sale −2,725 $1.21 $3K 62,860
2022-06-07 Boniface John J. Chief Scientific Officer Sale −2,725 $1.30 $4K 65,585
2022-06-03 Lawrence Sandra AJ Director Grant or award · Stock Option (right to buy) +149,675 149,675
2022-06-03 Trimble Ryan Director Grant or award · Stock Option (right to buy) +149,675 149,675
2022-06-03 Lindgardt Zhenya Director Grant or award · Stock Option (right to buy) +149,675 149,675

Page 18 of 23 · 457 trades